DRI Biosciences Corp Revenue

Biotechnology Research • Pleasant View, Maryland, United States • 1-10 Employees

DRI Biosciences Corp revenue & valuation

Annual revenue	$85,555
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$273,776
Total funding	No funding

Key Contact at DRI Biosciences Corp

Lawrence Horn

Chief Executive Officer

Company overview

Headquarters	4985 WINCHESTER BLVD, FREDERICK, Maryland 21703, US
Website	dribiosciences.com
Employees	1-10

About DRI Biosciences Corp

DRI Biosciences Corporation is developing proprietary and game-changing therapeutics to improve conditions of Fragile X Syndrome (FXS) and Autism Spectrum Disorder (ASD). FXS represents the most common form of inherited intellectual disability and is a frequent monogenic cause of autism. In the U.S. and Europe, there are more than 100,000 cases of FXS. Meanwhile, the total autistic incidence is approaching 2 million worldwide. The predicted therapeutic market is estimated at $5.5 billion by 2018, but there are no medications that effectively treat or improve these neurodevelopmental conditions.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

DRI Biosciences Corp has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

DRI Biosciences Corp has never raised funding before.

Frequently asked questions

DRI Biosciences Corp is located in Pleasant View, Maryland, US.

DRI Biosciences Corp generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.

DRI Biosciences Corp has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

DRI Biosciences Corp has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at DRI Biosciences Corp

Lawrence Horn

Chief Executive Officer

4.8

40,000 users